Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone plus pregabalin for herpes zoster-associated pain
ChiCTR1800019880Phase 4Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Dec 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydromorphone and pregabalin in herpes zoster (HZ) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Pain assessment. Started Dec 2018; status: recruiting.
02
Drugs
hydromorphonepregabalin
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ChiCTR1800019880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019880.